Advances in the treatment of Hodgkin's disease

A. Santoro, P. Valagussa

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Through the careful application of appropriate staging procedures and treatment modalities, at the beginning of the 1990s about 75% of patients with Hodgkin's disease can expect long-term remission or even cure. At present, radiotherapy remains the best therapeutic option for localized stages while advanced disease is cured by chemotherapy alone or chemotherapy combined with irradiation. In this decade, the challenge in the management of Hodgkin's disease will probably be represented by an optimal use of reasonably short-term chemotherapy regimens combined with limited-field irradiation in early stages and by an accurate evaluation of the best chemotherapy regimens for advanced disease. In the search for the optimal approaches to improve current therapeutic results, appropriate considerations should be given to the identification of effective treatment modalities with a minimum amount of acute and late toxicity.

Original languageEnglish
Pages (from-to)821-828
Number of pages8
JournalCurrent Opinion in Oncology
Volume4
Issue number5
Publication statusPublished - 1992

Fingerprint

Hodgkin Disease
Drug Therapy
Therapeutics
Radiotherapy

ASJC Scopus subject areas

  • Cancer Research

Cite this

Advances in the treatment of Hodgkin's disease. / Santoro, A.; Valagussa, P.

In: Current Opinion in Oncology, Vol. 4, No. 5, 1992, p. 821-828.

Research output: Contribution to journalArticle

Santoro, A. ; Valagussa, P. / Advances in the treatment of Hodgkin's disease. In: Current Opinion in Oncology. 1992 ; Vol. 4, No. 5. pp. 821-828.
@article{5327e724aed04ab6a27fb24e58c5501f,
title = "Advances in the treatment of Hodgkin's disease",
abstract = "Through the careful application of appropriate staging procedures and treatment modalities, at the beginning of the 1990s about 75{\%} of patients with Hodgkin's disease can expect long-term remission or even cure. At present, radiotherapy remains the best therapeutic option for localized stages while advanced disease is cured by chemotherapy alone or chemotherapy combined with irradiation. In this decade, the challenge in the management of Hodgkin's disease will probably be represented by an optimal use of reasonably short-term chemotherapy regimens combined with limited-field irradiation in early stages and by an accurate evaluation of the best chemotherapy regimens for advanced disease. In the search for the optimal approaches to improve current therapeutic results, appropriate considerations should be given to the identification of effective treatment modalities with a minimum amount of acute and late toxicity.",
author = "A. Santoro and P. Valagussa",
year = "1992",
language = "English",
volume = "4",
pages = "821--828",
journal = "Current Opinion in Oncology",
issn = "1040-8746",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Advances in the treatment of Hodgkin's disease

AU - Santoro, A.

AU - Valagussa, P.

PY - 1992

Y1 - 1992

N2 - Through the careful application of appropriate staging procedures and treatment modalities, at the beginning of the 1990s about 75% of patients with Hodgkin's disease can expect long-term remission or even cure. At present, radiotherapy remains the best therapeutic option for localized stages while advanced disease is cured by chemotherapy alone or chemotherapy combined with irradiation. In this decade, the challenge in the management of Hodgkin's disease will probably be represented by an optimal use of reasonably short-term chemotherapy regimens combined with limited-field irradiation in early stages and by an accurate evaluation of the best chemotherapy regimens for advanced disease. In the search for the optimal approaches to improve current therapeutic results, appropriate considerations should be given to the identification of effective treatment modalities with a minimum amount of acute and late toxicity.

AB - Through the careful application of appropriate staging procedures and treatment modalities, at the beginning of the 1990s about 75% of patients with Hodgkin's disease can expect long-term remission or even cure. At present, radiotherapy remains the best therapeutic option for localized stages while advanced disease is cured by chemotherapy alone or chemotherapy combined with irradiation. In this decade, the challenge in the management of Hodgkin's disease will probably be represented by an optimal use of reasonably short-term chemotherapy regimens combined with limited-field irradiation in early stages and by an accurate evaluation of the best chemotherapy regimens for advanced disease. In the search for the optimal approaches to improve current therapeutic results, appropriate considerations should be given to the identification of effective treatment modalities with a minimum amount of acute and late toxicity.

UR - http://www.scopus.com/inward/record.url?scp=0026761954&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026761954&partnerID=8YFLogxK

M3 - Article

VL - 4

SP - 821

EP - 828

JO - Current Opinion in Oncology

JF - Current Opinion in Oncology

SN - 1040-8746

IS - 5

ER -